Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: Long-term results of a prospective randomized study

International Journal of Radiation Oncology, Biology, Physics

Volumn 14, Issue 6, 1988, Pages 1085-1091

  Zagars, Gunar K ^a   Johnson, Douglas E ^a   von Eschenbach, Andrew C ^a   Hussey, David H ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Hormonal therapy; Radiation therapy; Randomized trial; Stage C adenocarcinoma of prostate

Indexed keywords

CHLOROTRIANISENE; DIETHYLSTILBESTROL;

ADULT; AGED; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PROSTATE CARCINOMA; RADIOTHERAPY;

ACTUARIAL ANALYSIS; ADENOCARCINOMA; CLINICAL TRIALS; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; DIETHYLSTILBESTROL; FOLLOW-UP STUDIES; HUMAN; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORCHIECTOMY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; RANDOM ALLOCATION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023680206     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(88)90383-5     Document Type: Article

References (33)

1. Early orchiectomy for patients with stage D1 prostatic carcinoma
2. Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo
3. Conservative treatment of early carcinoma of prostate. Comparison of patients less than seventy with those over seventy years of age
4. Carcinoma of the prostate: Biopsy and conservative therapy
5. The Veterans Administrative Cooperative Urological Research Group's studies of cancer of the prostate
6. The Veterans Administration Cooperative Urological Research Group's studies of conservative treatment
7. The Veterans Administration Cooperative Urological Research Group's studies of post-prostatectomy survival
8. The Veterans Administration Cooperative Urological Research Group's randomized trial of radical prostatectomy for stages I and II prostate cancer
9. The coronary drug project. Initial findings leading to modifications of its research protocol
10. Symptomatic stage C carcinoma of prostate. Traditional therapy
11. Carcinoma of the prostate: treatment with external radiotherapy
12. Orchiectomy versus oestrogen for prostatic cancer: cardiovascular effects
13. Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
14. Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone
15. Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer
16. Megavoltage radiation therapy for carcinoma of the prostate
17. Comparison of diethylstilbestrol, cyproterone acetate and med roxyprogesterone acetate in the treatment of advanced prostatic cancer: Final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group
18. Tumor control in definitive irradiation of localized carcinoma of the prostate
19. Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of life
20. Definitive radiation therapy of carcinoma of the prostate. A report on 15 years of experience
21. Radiotherapy for localized prostate carcinoma
22. The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer
23. Prostatic biopsy after irradiation therapy for prostatic cancer
24. New methods of endocrine management of prostatic cancer
25. Localized advanced carcinoma of the prostate: radiation therapy versus hormonal therapy
26. Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.
27. The clinical spectrum of prostate cancer
28. Stage C adenocarcinoma of the prostate: Analysis of 551 patients treated with external-beam radiation
29. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate
30. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C adenocarcinoma of prostate
31. Bilateral pelvic lymphandenectomy and radical retropubic prostatectomy for adenocarcinoma of prostate with regional lymph node involvement